Condensed Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Capital in Excess of Par Value	Retained Earnings	Retained Earnings Cumulative effect, period of adoption, adjustment	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss Cumulative effect, period of adoption, adjustment
Beginning balance (in shares) at Nov. 02, 2019		368,302
Beginning balance at Nov. 02, 2019		$ 61,385	$ 4,936,349	$ 6,899,253	$ 2,379	$ (187,799)	$ (2,379)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 203,874			203,874
Dividends declared and paid				(199,160)
Issuance of stock as charitable contribution (in shares)		336
Issuance of stock as charitable contribution		$ 56	39,944
Issuance of stock under stock plans and other (in shares)		491
Issuance of stock under stock plans and other		$ 82	16,031
Stock-based compensation expense			37,501
Other comprehensive income (loss)	$ (11,969)					(11,969)
Common stock repurchased (in shares)		(909)
Common stock repurchased		$ (152)	(105,878)
Ending balance (in shares) at Feb. 01, 2020		368,220
Ending balance at Feb. 01, 2020		$ 61,371	4,923,947	6,906,346		(202,147)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting standards update [extensible list]	us-gaap:AccountingStandardsUpdate201802Member
Beginning balance (in shares) at Oct. 31, 2020		369,485
Beginning balance at Oct. 31, 2020	$ 11,997,945	$ 61,582	4,949,586	7,236,238		(249,461)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	388,519			388,519
Dividends declared and paid				(229,179)
Issuance of stock under stock plans and other (in shares)		488
Issuance of stock under stock plans and other		$ 82	19,838
Stock-based compensation expense			36,638
Other comprehensive income (loss)	30,960					30,960
Common stock repurchased (in shares)		(1,079)
Common stock repurchased		$ (180)	(156,877)
Ending balance (in shares) at Jan. 30, 2021		368,894
Ending balance at Jan. 30, 2021	$ 12,087,746	$ 61,484	$ 4,849,185	$ 7,395,578		$ (218,501)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting standards update [extensible list]	us-gaap:AccountingStandardsUpdate201802Member